- Home
- MRK vs FITBO Comparison
MRK vs FITBO Comparison
Compare MRK & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | FITBO |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 18616 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | N/A |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | FITBO |
|---|---|---|
| Price | $117.85 | $19.05 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $123.67 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 15.7K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | $16.43 | ★ N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $19.06 |
| 52 Week High | $125.14 | $22.16 |
Technical Indicators
Market Signals| Indicator | MRK | FITBO |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 33.57 |
| Support Level | $113.27 | N/A |
| Resistance Level | $125.14 | $20.20 |
| Average True Range (ATR) | 2.35 | 0.20 |
| MACD | 0.23 | -0.03 |
| Stochastic Oscillator | 57.51 | 6.35 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of over $210 billion as of December 2025. The bank is set to close its acquisition of Comercia on Feb. 1, 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.